After 3,698 complaints, devicemaker recalls infusion pumps

An unspecified number of ambulatory infusion pumps were recalled because of nearly 3,700 complaints related to several product issues, the FDA said March 20. 

Advertisement

InfuTronix voluntarily recalled five types of its Nimbus Ambulatory Infusion Pump System after receiving 3,698 customer complaints between May 2019 and August 2023. The reports identified problems with battery power, medication infusion, potential leaks and flow rate. 

The medical device company said a third-party health hazard evaluation deemed a low risk of product failure, but it is redesigning the system.

“Given the number of anticipated design improvements and the extensive requirement for design, verification and validation, InfuTronix believes a new premarket notification and clearance from FDA may be required,” the March 20 post said. 

InfuTronix said the infusion pumps are safe to continue using during the removal process, and healthcare providers were reminded on how to recognize a potential device failure.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.